PTAB Invalidated Stratasys 3D Printing Patent Claims
The board ruled claims underlying a multi-million dollar judgment were obvious, limiting previous legal findings.
Updated on Oct. 1, 2026 in Biotech
Live Poll
Do you trust the current patent system to fairly handle challenges to jury-awarded damages?
The Patent Trial and Appeal Board has invalidated nearly all challenged claims across three Stratasys 3D printer patents. This regulatory decision impacts a portion of a larger trial verdict in the United States.
Why it matters
This decision curtails the scope of existing intellectual property in the additive manufacturing space. It specifically recalibrates the legal standing of a prior multi-million dollar trial judgment.
The PTAB determined that the challenged claims were obvious, invalidating $2.8 million of a $27.6 million trial verdict. These claims specifically pertained to the underlying 3D printing technology.
The players
Stratasys
A manufacturer of industrial 3D printing systems and additive manufacturing solutions.
Bambu Lab Ltd.
A developer of consumer and professional desktop 3D printers and additive manufacturing technology.
The details
The Patent Trial and Appeal Board reached this conclusion by evaluating whether the contested innovations met the legal standard of being obvious to a person having ordinary skill in the art. By ruling that the claims were obvious, the board essentially determined that the technology did not represent a sufficiently non-obvious advancement over existing knowledge. Bambu Lab Ltd. brought the challenge against the Stratasys portfolio, successfully narrowing the patent scope previously upheld in a Texas trial.
Timeline
September 30, 2026: The Patent Trial and Appeal Board invalidated the Stratasys patent claims.
The Tech Race
This ruling follows a pattern established by the 2011 America Invents Act's inter partes review process, which facilitates external challenges to patent validity. It demonstrates the continued use of administrative review to erode established patent moats within the competitive 3D printing industry.
This ruling reduces the legal leverage Stratasys holds over specific 3D printing technologies previously at the center of their Texas trial. It marks a shift for industry competitors who may now face fewer patent restrictions when developing similar additive hardware.
The takeaway
The invalidation demonstrates the volatility of patent-based market defenses in the hardware sector. Observers should track how this reduction in protected claims affects the final distribution of the original $27.6 million judgment.
Further reading
For broader trends in intellectual property litigation, visit our Biotech section.
Live Poll
Do you trust the current patent system to fairly handle challenges to jury-awarded damages?
